Showing results (61-70 of 333) with videos related to
Sort By:
Pageof 34
Journal of Neurovirology|April 25, 2012
Cytokine levels in CSF and neuropsychological performance in HIV patientsThorsten Nolting, Antje Lindecke, Hans-Peter Hartung, et al.Blood Advances|May 27, 2026
DUSP1 is a Key Driver of Disease Persistence and Potential Therapeutic Target in Hairy Cell LeukemiaJan-Paul Bohn, Alexandra Scheiber, Gregor Sturm, et al.Plos One|December 9, 2020
The prognostic value of Presepsin for postoperative complications following pancreatic resection: A prospective studySilvia Gasteiger, Florian Primavesi, Peter Werkl, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2015
CCR 20th Anniversary Commentary: From Regulatory T Cells to Checkpoint Monoclonal Antibodies--Immuno-oncology Advances Clinical Cancer ResearchDominik Wolf, Anna Maria WolfJournal of Neurovirology|December 17, 2009
Measurement of soluble inflammatory mediators in cerebrospinal fluid of human immunodeficiency virus-positive patients at distinct stages of infection by solid-phase protein arrayThorsten Nolting, Antje Lindecke, Eleni Koutsilieri, et al.Plos One|February 9, 2018
Immunophenotypic characterization of human T cells after in vitro exposure to different silicone breast implant surfacesGiuseppe Cappellano, Christian Ploner, Susanne Lobenwein, et al.Virology|February 8, 2003
Replication, immunogenicity, and protective properties of live-attenuated simian immunodeficiency viruses expressing interleukin-4 or interferon-gammaChristiane Stahl-Hennig, Björn R Gundlach, Ulf Dittmer, et al.Molecular Cancer|October 22, 2025
Ex vivo modelling of human colorectal cancer liver metastasis by normothermic machine perfusionManuel Trebo, Thomas Maurer, Felix J Krendl, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2009
Susceptibility to Simian immunodeficiency virus ex vivo predicts outcome of a prime-boost vaccine after SIVmac239 challengeWashingtone Ochieng, Ulrike Sauermann, Reiner Schulte, et al.Oncoimmunology|May 7, 2014
Implementing combinatorial immunotherapeutic regimens against cancer: The concept of immunological conditioningDominik Wolf, Annkristin Heine, Peter BrossartPageof 34